Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.

@article{Wernicke2007SeizureRI,
  title={Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.},
  author={Joachim Wernicke and Karen Chilcott Holdridge and Ling Jin and Timothy Edison and Shuyu Zhang and Mark E Bangs and Albert J. Allen and Susan D. Stewart Ball and David M Dunn},
  journal={Developmental medicine and child neurology},
  year={2007},
  volume={49 7},
  pages={498-502}
}
The comorbidity of seizures, epilepsy, and attention-deficit-hyperactivity disorder (ADHD) prompted the examination of whether atomoxetine use for ADHD is associated with an increased risk of seizures. Seizures and seizure-related symptoms were reviewed from two independent Eli Lilly and Company databases: the atomoxetine clinical trials database and the atomoxetine postmarketing spontaneous adverse event database. Review of clinical trial data indicated that the crude incidence rates of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Similar Papers

Loading similar papers…